HealthQuill diabetes management
Denmark’s Novo Nordisk declared its late-stage experimental once-weekly diabetes drug IcoSema achieved its primary endpoint of proving “non-inferiority” in lowering blood sugar levels.
Drugs Health Medical

Breakthrough treatment may end insulin use in type 2 diabetic patients

HQ Team October 15, 2024: A recent study presented at the United European Gastroenterology Week congress in Vienna unveiled a procedure that could.

Read More
A study to find solutions for treating two new variations of diabetes, type 4 and type 5, is underway in US research institutions as the overall disease population is expected to reach 783 million people by 2045.
Health Medical Pharma

New device uses infrared signals for accurate blood glucose levels

HQ Team March 29, 2024: The last few years have seen many innovative devices that help in monitoring blood sugar without finger pricks..

Read More
A study to find solutions for treating two new variations of diabetes, type 4 and type 5, is underway in US research institutions as the overall disease population is expected to reach 783 million people by 2045.
Drugs Health Medical

Hydrogel-based diabetes drug to cut need for insulin shots to thrice a year

HQ Team November 22, 2023: Stanford researchers have developed a promising hydrogel-based delivery system that will potentially transform diabetes treatment. This innovative technology,.

Read More
https://oag.ca.gov/news/press-releases/attorney-general-bonta-sues-nations-largest-insulin-makers-pharmacy-benefit
Drugs Health Medical Pharma

Study finds insulin can be stored at room temp without losing potency

HQ team November 3, 2023: Recent research by Cochrane has found that insulin can maintain its efficacy for extended periods at room temperature..

Read More